فرصت سرمایه گذاری در Dr20

In the Name of God, the Light — The Most Compassionate, the Most Merciful
Exceptional Investment Opportunity in Dr20 Medical Group
Dr20 Medical Group is a newly launched startup operating in three major fields:

Medical consultation and electronic prescriptions

Organized and professional medical tourism

Shopping center for licensed (herbal and conventional) medicines and branded medical equipment

Leveraging Artificial Intelligence (A.I.) and Telemedicine, Dr20 has officially begun its operations by the grace of God Almighty.
To build and expand its infrastructure (both software and hardware), Dr20 Medical Group is offering a limited 5% equity share of the company at half-price to early investors
To facilitate the share acquisition process for valued investors, Dr20 Medical Group’s total capital is divided into 1,000 shares, and 50 shares (5%) will be available for individual or bulk purchase at a 50% discount, during the period:
[20May 2025 till 20 June 2025]
(30 Ordibehesht – 30 Khordad, 1404 in the Persian calendar)
Key Highlights:

Your investment will be made and guaranteed in foreign currency (USD or EUR), and this will be explicitly stated in the official share purchase agreement.

You will pay in cash (USD or EUR), and when you decide to sell, Dr20 Medical Group will buy back your shares in the same format (cash in USD or EUR).

This method of foreign currency investment is similar to practices of most Iranian banks, thus helping preserve the value of your capital against local currency fluctuations.

Legal Guarantee: The number of shares you purchase will be officially recorded at a Notary Public Office as a legal transfer agreement. You will retain the right to sell your shares to Dr20 Medical Group or any third party at a mutually agreed price, anytime.

Benefits of Investing in Dr20 Medical Group:

Multilingual Website Access:
Dr20 has planned and structured its platform to support multiple languages. Within three months, the following languages will be integrated:
Arabic, German, Japanese, French, English, Italian, and Spanish.

Supporting Domains for Higher Visibility:
To increase traffic and visibility for the main website www.Dr20.org, the following supplementary domains will be actively utilized:

www.Dr20.net

www.Dr20.info

www.Dr20.education

www.Dr20.shop

www.Dr20.biz

Educational, Scientific, Cultural, and Artistic Content:
This content will be published and promoted via the main domain (.org) and the five supporting domains listed above.

For inquiries on pricing and share purchase terms, please contact:

Main Share Sales Consultant: Mr Esmaeil Hemmati 09175003670
Dr20 Medical Group Office (during business hours)
Or the Managing Director of Dr20 Medical Group:
Dr. M.Saffar.MD
Mobile: +98 917 102 0676